Role of Glutamine as Myocardial Protector in Elective On-Pump Coronary Artery Bypass Graft Surgery With Low Ejection Fraction
Conditions: Coronary Artery Bypass; Cardiopulmonary Bypass; Coronary Artery Disease Interventions: Drug: L-alanyl-L-glutamine dipeptide; Drug: Placebo Sponsor: National Cardiovascular Center Harapan Kita Hospital Indonesia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Coronary Artery Bypass Graft | Heart | Hospitals | Indonesia Health | Research